CELL AND GENE THERAPY INSIGHTS

Overcoming Downstream Bottlenecks

July 2017
Overcoming Downstream Bottlenecks
Download PDF

Expert Insight

Considerations for the bioprocessing, manufacture and translation of extracellular vesicles for therapeutic applications

Considerations for the bioprocessing, manufacture and translation of extracellular vesicles for therapeutic applications

Owen Davies, Qasim Rafiq
20 November 2017
Read
Advances and challenges in umbilical cord blood and tissue bioprocessing: procurement and storage

Advances and challenges in umbilical cord blood and tissue bioprocessing: procurement and storage

L Parker, S Mansfield, K Sneddon et al.
4 August 2017
Read
Bioprocess engineering strategies for autologous human MSC-based therapies: one size does not fit all

Bioprocess engineering strategies for autologous human MSC-based therapies: one size does not fit all

Ioannis Papantoniou, Toon Lambrechts, Jean-Marie Aerts
4 August 2017
Read
Challenges and advances in scale-up of label-free downstream processing for allogeneic cell therapies

Challenges and advances in scale-up of label-free downstream processing for allogeneic cell therapies

F Masri, M Hoeve, P de Sousa et al.
4 August 2017
Read

Innovator Insight

The importance of fill & finish in the commercialization of your cell & gene therapy

The importance of fill & finish in the commercialization of your cell & gene therapy

Jean-Sebastien Parisse
4 August 2017
Read

Interview

Advances in the development of bioprocesses for vaccines and viral vectors for gene therapy

Advances in the development of bioprocesses for vaccines and viral vectors for gene therapy

Manuel Carrondo
4 August 2017
Read